Patents by Inventor Robert Alan Reid

Robert Alan Reid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5835935
    Abstract: A semiconductor non-volatile mass storage memory is partitioned into user files and system files. The system files partition is further subdivided into clusters, each cluster having a plurality of sectors. Each cluster stores the system file for a single predetermined LBA. As the information within the LBA is changed, the new information is written into an empty sector within the cluster. Once the cluster is filled, the system either erases for recycling the cluster or preferably locates an empty cluster and repeats the process with that new cluster. Once all the clusters are filled, all clusters containing old data are erased for recycling.
    Type: Grant
    Filed: September 13, 1995
    Date of Patent: November 10, 1998
    Assignee: Lexar Media, Inc.
    Inventors: Petro Estakhri, Mahmud Assar, Robert Alan Reid, Berhanu Iman
  • Patent number: 5756702
    Abstract: Thermophilic Strand Displacement Amplification (tSDA) for amplification of nucleic acid target sequences in situ in cells in suspension, on slides or in tissues is described. Excellent specimen morphology is preserved, and either DNA targets, RNA targets, or both may be selectively amplified. In situ amplification by tSDA is compatible with immunochemical techniques, so that both amplification of target sequences and immunological staining can be perfonned on the same specimen.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: May 26, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: Kenton L. Lohman, Natalie V. Ostrerova, Mark Van Cleve, Robert Alan Reid
  • Patent number: 5739289
    Abstract: A human brain glycoprotein homologous to the mouse F3 and the chicken contactin/F11 adhesion molecules, nucleic acid sequences encoding the human brain glycoprotein and antibodies directed against the human brain glycoprotein.
    Type: Grant
    Filed: September 17, 1996
    Date of Patent: April 14, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: Robert Alan Reid, John Jacob Hemperly
  • Patent number: 5733752
    Abstract: Thermophilic Strand Displacement Amplification (tSDA) for amplification of nucleic acid target sequences in situ in cells in suspension, on slides or in tissues is described. Excellent specimen morphology is preserved, and either DNA targets, RNA targets, or both may be selectively amplified. In situ amplification by tSDA is compatible with immunochemical techniques, so that both amplification of target sequences and immunological staining can be performed on the same specimen.
    Type: Grant
    Filed: September 21, 1995
    Date of Patent: March 31, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: Kenton L. Lohman, Natalie V. Ostrerova, Mark Van Cleve, Robert Alan Reid
  • Patent number: 5731154
    Abstract: A human brain glycoprotein homologous to the mouse F3 and the chicken contactin/F11 adhesion molecules is provided. Also described are nucleic acid sequences encoding the human brain glycoprotein and antibodies directed against the human brain glycoprotein.
    Type: Grant
    Filed: March 21, 1995
    Date of Patent: March 24, 1998
    Assignee: Becton, Dickinson and Company
    Inventors: Robert Alan Reid, John Jacob Hemperly
  • Patent number: 5688916
    Abstract: A human brain glycoprotein homologous to the mouse F3 and the chicken contactin/F11 adhesion molecules, nucleic acid sequences encoding the human brain glycoprotein and antibodies directed against the human brain glycoprotein.
    Type: Grant
    Filed: March 21, 1995
    Date of Patent: November 18, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: Robert Alan Reid, John Jacob Hemperly
  • Patent number: 5681931
    Abstract: Human restrictin proteins and nucleic acid sequences encoding them are provided. Antibodies which recognize human restrictin in human brain are disclosed. In the human brain, restrictin occurs as two major polypeptides of 180 and 160 kD located in fiber tracts. These polypeptides are similar to those seen in rat brain. Surprisingly, restrictin has also been found in the peripheral nerves of rats and humans. The antibodies also detect a 170 kD polypeptide in MATRIGEL, an extracellular matrix product of rat EHS sarcoma cells widely used as a tissue culture substrate. Monoclonal antibodies to human restrictin and assays using the human restrictin protein, antibodies and DNA sequences are also provided.
    Type: Grant
    Filed: March 15, 1995
    Date of Patent: October 28, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: Robert Alan Reid, Rhonda Lucille Ackley, John Jacob Hemperly